| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ARGOS THERAPEUTICS INC | 13,242,279 | 64,887,000 | 55.88% | ||
| 2 | ARGOS THERAPEUTICS INC | 5,120,604 | 27,390,000 | 23.59% | Call | |
| 3 | Protagonist Therapeutics, Inc. | 983,570 | 21,628,000 | 18.63% | ||
| 4 | Proteon Therapeutics | 1,165,344 | 2,214,000 | 1.91% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-001877, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
